Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Ludwig Oxford round up another successful year
17 December 2024
Publications
-
Atkinson G. et al, (2025), Bulletin of Mathematical Biology, 87
-
Schoenpflug LA. et al, (2025), The Journal of Pathology, 265, 184 - 197
-
Matthews PC. et al, (2025), JHEP Reports, 7, 101280 - 101280
Seminars
